Private company

Kyto Technology & Life Science, Inc.

Kyto Technology & Life Science, Inc. is an American pharmaceutical preparations company, incorporated in Delaware.1 It is headquartered in Los Altos Hills, California.1

Last updated Oct 20, 2026.

Overview

$427.1KNet income, fiscal 20212
  • IndustryPharmaceutical Preparations1
  • HeadquartersLos Altos Hills, California1
  • Incorporated inDE3
  • Business address13050 Paloma Road, Los Altos Hills, Ca 940223
  • Filer categoryNon-accelerated filer, Smaller reporting company3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2020

-5034.3%Gross margin2
-5465.7%Operating margin4
-5465.7%Net margin2
57.2%Revenue growth, 20204
-29.0%Return on equity2
-$3.2MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2020

  • Other costs100¢$14.2K

Out of $14.2K in revenue.42 The company lost money this year.

Financial statements

Revenue54$14.2K in 2020
0$5.0K$10.0K$15.0K2018: $0$020182019: $9.0K$9.0K20192020: $14.2K$14.2K2020+57%
Operating income54-$773.4K in 2020+752% since 2018
-$800.0K-$600.0K-$400.0K-$200.0K02018: -$90.8K-$90.8K20182019: -$230.1K-$230.1K2019+153%2020: -$773.4K-$773.4K2020+236%
Net income542-$773.4K in 2020+752% since 2018
-$800.0K-$600.0K-$400.0K-$200.0K02018: -$90.8K-$90.8K20182019: -$230.1K-$230.1K2019+153%2020: -$773.4K-$773.4K2020+236%
Fiscal year20162017201820192020
Revenue$05$9.0K4$14.2K4
Gross profit-$712.4K2
Operating income-$90.8K5-$230.1K4-$773.4K4
Income tax$05$04$04
Net income-$90.8K5-$230.1K4-$773.4K2
Earnings per share-$0.132
Earnings per share (diluted)-$0.132

Compare Kyto Technology & Life Science, Inc. with another company

What it owns

What Kyto Technology & Life Science, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

ItemLatestA year beforeChange
Marketable securities, non-current$2.7M4 Mar 31, 2020$1.5M4 Mar 31, 2019+77.9%

Leadership

Who has led Kyto Technology & Life Science, Inc., and when. Pick a name to see everywhere that person has worked.

2010201520202025
Board members and other officers (2)

Former names

  • KYTO BIOPHARMA INCSep 12, 2003 to Jun 28, 20183
  • B TWELVE INCJan 18, 2002 to May 21, 20033

Timeline

  1. May 9, 20228-K Other events10
  2. Feb 9, 20228-K Unregistered sale of shares11
  3. Nov 10, 20218-K Executive or director change12
  4. Oct 12, 20218-K Bylaws or fiscal year changed13

Filings

22 filings to the SEC since October 2021: 4 quarterly reports, 4 major events, 14 other. The latest 20:

  1. May 12, 202215-12G EDGAR
  2. May 9, 2022S-8 POS EDGAR
  3. May 9, 2022SC TO-I/A EDGAR
  4. May 9, 20228-K EDGAR
  5. May 5, 2022SC TO-I/A EDGAR
  6. May 4, 2022SC TO-I/A EDGAR
  7. Apr 22, 2022CORRESP EDGAR
  8. Apr 22, 2022SC TO-I/A EDGAR
  9. Apr 18, 2022UPLOAD EDGAR
  10. Apr 12, 2022UPLOAD EDGAR
  11. Apr 1, 2022SC TO-I EDGAR
  12. Mar 23, 2022CORRESP EDGAR
  13. Feb 22, 202210-Q EDGAR
  14. Feb 15, 2022NT 10-Q EDGAR
  15. Feb 9, 20228-K EDGAR
  16. Feb 2, 2022UPLOAD EDGAR
  17. Nov 18, 202110-Q EDGAR
  18. Nov 16, 2021NT 10-Q EDGAR
  19. Nov 10, 20218-K EDGAR
  20. Oct 12, 20218-K EDGAR

The 22 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How Kyto Technology & Life Science, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARKyto Technology & Life Science, Inc.1
  • CIK0001164888
  • Employer ID (EIN)65-10865381
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsMarch 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • Business address13050 Paloma Road, Los Altos Hills, CA 940221
  • Phone650-204-78961
  • Shares outstanding13,287,621 as of Feb 18, 20226
  • Public float$973.9K as of Sep 30, 20202
  • On EDGAR sinceJan 18, 20021
  • Filings212 in all: 10-Q (42), 8-K (30), 4 (18), UPLOAD (15), 10QSB (14), 10-K (13), CORRESP (11), NT 10-Q (8)1
    All 34 form types

    10-K/A (6), 10-Q/A (6), SC 13D (6), SC TO-I/A (6), 10KSB (5), 3 (5), 10KSB/A (2), 4/A (2), 5 (2), NT 10-K (2), PRER14A (2), SB-2/A (2), SC TO-I (2), 10SB12G (1), 15-12G (1), 425 (1), D (1), DEF 14A (1), NTN 10Q (1), PRE 14A (1), RW (1), S-8 (1), S-8 POS (1), SB-2 (1), SC 13G (1), SC 13G/A (1)

  • Latest filingsAnnual report (10-K) Aug 10, 2021
    Quarterly report (10-Q) Feb 22, 2022
    Proxy statement (DEF 14A) Jun 17, 2019
    Latest 8-K (8-K) May 9, 2022